<DOC>
	<DOC>NCT01532336</DOC>
	<brief_summary>The purpose of this study is to evaluate the clinical and microbiological efficacy and safety of NVC-422 compared to vehicle for adenoviral conjunctivitis. Adults and children one year of age and older with diagnosis of adenoviral conjunctivitis in at least one eye based upon a positive adenovirus test result using the Aden-Detactor Plus kit (Rapid Pathogen Screening, Inc). Subjects will be randomly assigned to receive either NVC-422 or Vehicle.</brief_summary>
	<brief_title>Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis</brief_title>
	<detailed_description>This is a randomized (1:1) double-masked, vehicle-controlled, multi-center, parallel group study with two treatment arms: NVC-422 Ophthalmic Solution 0.33% ("NVC-422") and NVC-422 Vehicle ("Vehicle"). Subjects that meet all inclusion/exclusion criteria will be enrolled into the study, randomized and evaluated at 6 visits: - Visit 1: Screening, Day 1 - Visit 2: Day 3 - Visit 3: Day 6 - Visit 4: Day 11 End of Treatment (EOT) - Visit 5: Day 18 Test-of-Cure (TOC) - Visit 6: Day 42 Follow-up Subjects were dosed OU for 10 days. Specimens were collected OU at each visit for quantitative PCR adenoviral load and molecular typing.</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Inclusion</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Signs and symptoms of viral conjunctivitis in at least one eye for 3 days or less Bulbar conjunctival injection Other inclusion criteria per protocol Presence of subepithelial infiltrates (SEIs) at the Day 1 visit in either eye A suspected bacterial, fungal, herpes, Chlamydia or Acanthamoeba coinfection, based on clinical observation Other exclusion criteria per protocol</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>adenovirus</keyword>
	<keyword>conjunctivitis</keyword>
	<keyword>pinkeye</keyword>
</DOC>